⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PYXS News
Pyxis Oncology, Inc. Common Stock
Form 8-K
sec.gov
PYXS
Form 8-K
sec.gov
PYXS
Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
globenewswire.com
PYXS
Pyxis Oncology to Participate in Upcoming Investor Conferences
globenewswire.com
PYXS
Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer
globenewswire.com
PYXS
Form 8-K/A
sec.gov
PYXS
Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026
globenewswire.com
PYXS
Form 8-K
sec.gov
PYXS
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
PYXS
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity
globenewswire.com
PYXS
AMGN
MRK